BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen J, Li C, Gao X, Li C, Liang Z, Yu L, Li Y, Xiao X, Chen L. Keratinocyte growth factor gene delivery via mesenchymal stem cells protects against lipopolysaccharide-induced acute lung injury in mice. PLoS One 2013;8:e83303. [PMID: 24367590 DOI: 10.1371/journal.pone.0083303] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Z, Kuang Y, Ma K, Li Y, Liu X, Shi Y, Wu X. Gclc overexpression inhibits apoptosis of bone marrow mesenchymal stem cells through the PI3K/AKT/Foxo1 pathway to alleviate inflammation in acute lung injury. International Immunopharmacology 2022;110:109017. [DOI: 10.1016/j.intimp.2022.109017] [Reference Citation Analysis]
2 Wang S, Lei B, Zhang E, Gong P, Gu J, He L, Han L, Yuan Z. Targeted Therapy for Inflammatory Diseases with Mesenchymal Stem Cells and Their Derived Exosomes: From Basic to Clinics. IJN 2022;Volume 17:1757-81. [DOI: 10.2147/ijn.s355366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Liu J, Dean DA. Gene Therapy for Acute Respiratory Distress Syndrome. Front Physiol 2022;12:786255. [DOI: 10.3389/fphys.2021.786255] [Reference Citation Analysis]
4 Xu Z, Huang Y, Zhou J, Deng X, He W, Liu X, Li Y, Zhong N, Sang L. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS. Front Immunol 2021;12:738697. [PMID: 34659231 DOI: 10.3389/fimmu.2021.738697] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Shaw TD, Krasnodembskaya AD, Schroeder GN, Zumla A, Maeurer M, O'Kane CM. Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases. Clin Microbiol Rev 2021;:e0006421. [PMID: 34612662 DOI: 10.1128/CMR.00064-21] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Kronstadt SM, Pottash AE, Levy D, Wang S, Chao W, Jay SM. Therapeutic Potential of Extracellular Vesicles for Sepsis Treatment. Adv Ther (Weinh) 2021;4:2000259. [PMID: 34423113 DOI: 10.1002/adtp.202000259] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Abdelgawad M, Bakry NS, Farghali AA, Abdel-Latif A, Lotfy A. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects. Stem Cell Res Ther 2021;12:469. [PMID: 34419143 DOI: 10.1186/s13287-021-02542-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Fengyun W, LiXin Z, Xinhua Q, Bin F. Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis. Cell Transplant 2020;29:963689720969186. [PMID: 33164559 DOI: 10.1177/0963689720969186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
9 Chen J, Li C, Liang Z, Li C, Li Y, Zhao Z, Qiu T, Hao H, Niu R, Chen L. Human mesenchymal stromal cells small extracellular vesicles attenuate sepsis-induced acute lung injury in a mouse model: the role of oxidative stress and the mitogen-activated protein kinase/nuclear factor kappa B pathway. Cytotherapy 2021:S1465-3249(21)00689-7. [PMID: 34272174 DOI: 10.1016/j.jcyt.2021.05.009] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Varkouhi AK, Monteiro APT, Tsoporis JN, Mei SHJ, Stewart DJ, Dos Santos CC. Genetically Modified Mesenchymal Stromal/Stem Cells: Application in Critical Illness. Stem Cell Rev Rep 2020;16:812-27. [PMID: 32671645 DOI: 10.1007/s12015-020-10000-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
11 Wang J, Huang R, Xu Q, Zheng G, Qiu G, Ge M, Shu Q, Xu J. Mesenchymal Stem Cell-Derived Extracellular Vesicles Alleviate Acute Lung Injury Via Transfer of miR-27a-3p. Crit Care Med. 2020;48:e599-e610. [PMID: 32317602 DOI: 10.1097/ccm.0000000000004315] [Cited by in Crossref: 18] [Cited by in F6Publishing: 41] [Article Influence: 18.0] [Reference Citation Analysis]
12 Gorman E, Millar J, McAuley D, O'Kane C. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential. Expert Rev Respir Med 2021;15:301-24. [PMID: 33172313 DOI: 10.1080/17476348.2021.1848555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
13 Oroojalian F, Haghbin A, Baradaran B, Hemmat N, Shahbazi MA, Baghi HB, Mokhtarzadeh A, Hamblin MR. Novel insights into the treatment of SARS-CoV-2 infection: An overview of current clinical trials. Int J Biol Macromol 2020;165:18-43. [PMID: 32991900 DOI: 10.1016/j.ijbiomac.2020.09.204] [Cited by in Crossref: 15] [Cited by in F6Publishing: 24] [Article Influence: 7.5] [Reference Citation Analysis]
14 Hamdan H, Hashmi SK, Lazarus H, Gale RP, Qu W, El Fakih R. Promising role for mesenchymal stromal cells in coronavirus infectious disease-19 (COVID-19)-related severe acute respiratory syndrome? Blood Rev 2021;46:100742. [PMID: 32854985 DOI: 10.1016/j.blre.2020.100742] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Byrnes D, Masterson CH, Artigas A, Laffey JG. Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome. Semin Respir Crit Care Med 2021;42:20-39. [PMID: 32767301 DOI: 10.1055/s-0040-1713422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
16 Raza SS, Khan MA. Mesenchymal Stem Cells: A new front emerge in COVID19 treatment. Cytotherapy 2020. [DOI: 10.1016/j.jcyt.2020.07.002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
17 Qin H, Zhao A. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics. Protein Cell. 2020. [PMID: 32519302 DOI: 10.1007/s13238-020-00738-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 46] [Article Influence: 13.0] [Reference Citation Analysis]
18 Yang X, Ma X, Don O, Song Y, Chen X, Liu J, Qu J, Feng Y. Mesenchymal stem cells combined with liraglutide relieve acute lung injury through apoptotic signaling restrained by PKA/β-catenin. Stem Cell Res Ther 2020;11:182. [PMID: 32429994 DOI: 10.1186/s13287-020-01689-5] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Sadeghian Chaleshtori S, Mokhber Dezfouli MR, Jabbari Fakhr M. Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases. Respir Res 2020;21:110. [PMID: 32393278 DOI: 10.1186/s12931-020-01373-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Behnke J, Kremer S, Shahzad T, Chao CM, Böttcher-Friebertshäuser E, Morty RE, Bellusci S, Ehrhardt H. MSC Based Therapies-New Perspectives for the Injured Lung. J Clin Med 2020;9:E682. [PMID: 32138309 DOI: 10.3390/jcm9030682] [Cited by in Crossref: 51] [Cited by in F6Publishing: 67] [Article Influence: 25.5] [Reference Citation Analysis]
21 Han J, Liu Y, Liu H, Li Y. Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome. Stem Cell Res Ther 2019;10:386. [PMID: 31843004 DOI: 10.1186/s13287-019-1518-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
22 Han J, Li Y, Li Y. Strategies to Enhance Mesenchymal Stem Cell-Based Therapies for Acute Respiratory Distress Syndrome. Stem Cells Int 2019;2019:5432134. [PMID: 31885615 DOI: 10.1155/2019/5432134] [Cited by in Crossref: 8] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
23 Silva JD, Lopes-Pacheco M, Paz AHR, Cruz FF, Melo EB, de Oliveira MV, Xisto DG, Capelozzi VL, Morales MM, Pelosi P, Cirne-Lima E, Rocco PRM. Mesenchymal Stem Cells From Bone Marrow, Adipose Tissue, and Lung Tissue Differentially Mitigate Lung and Distal Organ Damage in Experimental Acute Respiratory Distress Syndrome. Crit Care Med. 2018;46:e132-e140. [PMID: 29116998 DOI: 10.1097/ccm.0000000000002833] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 12.7] [Reference Citation Analysis]
24 Zhang C, Zhu Y, Wang J, Hou L, Li W, An H. CXCR4-Overexpressing Umbilical Cord Mesenchymal Stem Cells Enhance Protection against Radiation-Induced Lung Injury. Stem Cells Int 2019;2019:2457082. [PMID: 30867667 DOI: 10.1155/2019/2457082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
25 Shao Y, Shen J, Zhou F, He D. Mesenchymal stem cells overexpressing Ang1 attenuates phosgene-induced acute lung injury in rats. Inhal Toxicol 2018;30:313-20. [PMID: 30395743 DOI: 10.1080/08958378.2018.1521483] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
26 Yabuki H, Wakao S, Kushida Y, Dezawa M, Okada Y. Human Multilineage-differentiating Stress-Enduring Cells Exert Pleiotropic Effects to Ameliorate Acute Lung Ischemia-Reperfusion Injury in a Rat Model. Cell Transplant 2018;27:979-93. [PMID: 29707971 DOI: 10.1177/0963689718761657] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
27 Kotnala S, Tyagi A, Muyal JP. rHuKGF ameliorates protease/anti-protease imbalance in emphysematous mice. Pulmonary Pharmacology & Therapeutics 2017;45:124-35. [DOI: 10.1016/j.pupt.2017.05.013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
28 Mei SH, Dos Santos CC, Stewart DJ. Advances in Stem Cell and Cell-Based Gene Therapy Approaches for Experimental Acute Lung Injury: A Review of Preclinical Studies. Hum Gene Ther 2016;27:802-12. [PMID: 27531647 DOI: 10.1089/hum.2016.063] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
29 Kotnala S, Baghel S, Verma D, Tyagi A, Muyal JP. Recombinant human keratinocyte growth factor attenuates apoptosis in elastase induced emphysematous mice lungs. Inhalation Toxicology 2017;29:23-31. [DOI: 10.1080/08958378.2016.1272653] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Cruz FF, Weiss DJ, Rocco PRM. Prospects and progress in cell therapy for acute respiratory distress syndrome. Expert Opinion on Biological Therapy 2016;16:1353-60. [DOI: 10.1080/14712598.2016.1218845] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
31 Kishi H, Sato M, Shibata Y, Sato K, Inoue S, Abe S, Kimura T, Nishiwaki M, Yamauchi K, Nemoto T, Igarashi A, Tokairin Y, Nakajima O, Kubota I. Role of chemokine C-C motif ligand-1 in acute and chronic pulmonary inflammations. Springerplus 2016;5:1241. [PMID: 27536524 DOI: 10.1186/s40064-016-2904-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
32 Hu Y, Qin C, Zheng G, Lai D, Tao H, Zhang Y, Qiu G, Ge M, Huang L, Chen L, Cheng B, Shu Q, Xu J. Mesenchymal Stem Cell-Educated Macrophages Ameliorate LPS-Induced Systemic Response. Mediators Inflamm 2016;2016:3735452. [PMID: 27546994 DOI: 10.1155/2016/3735452] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
33 Savukinas UB, Enes SR, Sjöland AA, Westergren-Thorsson G. Concise Review: The Bystander Effect: Mesenchymal Stem Cell-Mediated Lung Repair. Stem Cells 2016;34:1437-44. [PMID: 26991735 DOI: 10.1002/stem.2357] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
34 Yang C, Jiang J, Yang X, Wang H, Du J. Stem/progenitor cells in endogenous repairing responses: new toolbox for the treatment of acute lung injury. J Transl Med 2016;14:47. [PMID: 26865361 DOI: 10.1186/s12967-016-0804-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
35 Nowakowski A, Walczak P, Janowski M, Lukomska B. Genetic Engineering of Mesenchymal Stem Cells for Regenerative Medicine. Stem Cells Dev. 2015;24:2219-2242. [PMID: 26140302 DOI: 10.1089/scd.2015.0062] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
36 Chen J, Li C, Chen L. The Role of Microvesicles Derived from Mesenchymal Stem Cells in Lung Diseases. Biomed Res Int. 2015;2015:985814. [PMID: 26064975 DOI: 10.1155/2015/985814] [Cited by in Crossref: 13] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
37 Mammoto T, Jiang A, Jiang E, Mammoto A. Platelet-rich plasma extract prevents pulmonary edema through angiopoietin-Tie2 signaling. Am J Respir Cell Mol Biol 2015;52:56-64. [PMID: 24960457 DOI: 10.1165/rcmb.2014-0076OC] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
38 Gotts JE, Abbott J, Matthay MA. Influenza causes prolonged disruption of the alveolar-capillary barrier in mice unresponsive to mesenchymal stem cell therapy. Am J Physiol Lung Cell Mol Physiol 2014;307:L395-406. [PMID: 25038188 DOI: 10.1152/ajplung.00110.2014] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 6.4] [Reference Citation Analysis]
39 Tong L, Bi J, Zhu X, Wang G, Liu J, Rong L, Wang Q, Xu N, Zhong M, Zhu D, Song Y, Bai C. Keratinocyte growth factor-2 is protective in lipopolysaccharide-induced acute lung injury in rats. Respir Physiol Neurobiol 2014;201:7-14. [PMID: 24973472 DOI: 10.1016/j.resp.2014.06.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]